US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

THEMES US R&D CHAMPIONS ETF

37.24

0.0000

Volume:- -

Turnover:- -

Market Cap:1.12M

PE:- -

High:37.24

Open:37.24

Low:37.24

Close:37.24

52wk High:39.83

52wk Low:30.96

Shares:30.00K

Float Shares:30.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.14

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Dimerix Secures Long-Term U.S. Patent Protection for Phase 2 Kidney Drug DMX-652

Vision Marine files U.S. patent application for marine power management

Hohhot Strengthens Intellectual Property Safeguards for Companies Expanding Overseas

InterDigital Signs Patent License Agreement With Keba Energy Automation

MT Newswires Live

Zhongsheng Pharmaceutical's Unit Gets Patent From Japan for Polypeptide Drug

MT Newswires Live

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination

Entropy Neurodynamics Granted South African Patent for Fibromyalgia Treatment Using Psilocybin

MT Newswires Live

VisionWave files provisional patent application for GhostSight

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Nuwellis awarded U.S. patent for Dual Lumen Catheter

Hainan Province Launches "One-Stop" Service Zone for Intellectual Property Protection

UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103

NewcelX announces Brazil patent for cell selection, enrichment technology

enVVeno Medical highlights newly issued U.S. patent

UroGen Pharma Receives US Patent Allowance for Zusduri, UGN-103

MT Newswires Live

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Seyond Holdings Reports Mixed Outcomes in LiDAR Patent Fight With Hesai

Immutep Granted New US Patent for Cancer Treatment Methods

MT Newswires Live

VisionWave Files Provisional Patent Application for SkyWeave Communication System

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/USRD/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"USRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","market":"US","secType":"STK","nameCN":"THEMES US R&D CHAMPIONS ETF","latestPrice":37.237,"timestamp":1787342400000,"preClose":37.237,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:00:00 EDT","open":37.237,"high":37.237,"low":37.237,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.237,"sharesOutstanding":30000,"nav":37.28,"aum":1118400,"dividendRate":0.003776,"bidAskSpread":0,"volumeRatio":0,"impliedVol":0.1087,"impliedVolPercentile":0.1772},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.1406,"high":37.237,"amplitude":0,"preClose":37.237,"low":37.237,"week52Low":30.96,"pbRate":"--","week52High":39.83,"institutionHeld":0,"latestPrice":37.237,"eps":0,"divideRate":0.003776,"volume":0,"delay":0,"ttmEps":0,"open":37.237,"prevYearClose":33.9934,"prevWeekClose":37.237,"prevMonthClose":37.237,"prevQuarterClose":37.1571,"fiveDayClose":37.237,"twentyDayClose":36.4783,"sixtyDayClose":37.8873},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/USRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-29","symbol":"USRD","reason":null,"defaultRemindTime":1785331800000,"announcedDate":"2026-07-28","type":"delisting","dateTimestamp":1785297600000},{"date":"2025-12-18","symbol":"USRD","amount":0.1402666,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-19"},{"date":"2024-12-24","symbol":"USRD","amount":0.72425,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"USRD\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.72425,"currency":"USD"},{"executeDate":"2025-12-18","recordDate":"2025-12-18","paymentDate":"2025-12-19","value":0.1402666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"USRD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"USRD\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653917027","title":"Dimerix Secures Long-Term U.S. Patent Protection for Phase 2 Kidney Drug DMX-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2653917027","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653917027?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:04","pubTimestamp":1784761493,"startTime":"0","endTime":"0","summary":"Dimerix Limited ( ($AU:DXB) ) has shared an announcement. Dimerix Limited has secured a U.S. composition of matter patent for its newly acquired Ph...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerix-secures-long-term-u-s-patent-protection-for-phase-2-kidney-drug-dmx-652?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerix-secures-long-term-u-s-patent-protection-for-phase-2-kidney-drug-dmx-652?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DMX","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653755117","title":"Vision Marine files U.S. patent application for marine power management","url":"https://stock-news.laohu8.com/highlight/detail?id=2653755117","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653755117?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:10","pubTimestamp":1784711420,"startTime":"0","endTime":"0","summary":"Vision Marine Technologies (VMAR) announced the filing of a new U.S. patent application relating to low-voltage power distribution and selective lo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vision-marine-files-u-s-patent-application-for-marine-power-management-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vision-marine-files-u-s-patent-application-for-marine-power-management-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VMAR","BK4190","USRD","MTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136089148","title":"Hohhot Strengthens Intellectual Property Safeguards for Companies Expanding Overseas","url":"https://stock-news.laohu8.com/highlight/detail?id=1136089148","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136089148?lang=en_us&edition=fundamental","pubTime":"2026-07-21 22:30","pubTimestamp":1784644233,"startTime":"0","endTime":"0","summary":"Hohhot is implementing measures to support the development of the China (Inner Mongolia) Pilot Free Trade Zone Hohhot Area and to address specific challenges faced by companies regarding...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTNT","BK4139","LRND","USRD","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653270905","title":"InterDigital Signs Patent License Agreement With Keba Energy Automation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653270905","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653270905?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:53","pubTimestamp":1784638421,"startTime":"0","endTime":"0","summary":"InterDigital  has signed a new patent license agreement with Germany's Keba Energy Automation, InterDigital said Tuesday.Financial details of the agreement were not disclosed.The agreement covers a number of Keba EV charger products under InterDigital's patent portfolio related to 3G, 4G and Wi-Fi standards, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DAT","LU1303367103.USD","BK4023","IDCC","USRD","LU2098885051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653276202","title":"Zhongsheng Pharmaceutical's Unit Gets Patent From Japan for Polypeptide Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2653276202","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653276202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 16:17","pubTimestamp":1784621836,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical's  unit, Guangdong Zhong Sheng Ruichuang Biotechnology, received a patent certificate from Japan's patent regulator for a method for a polypeptide drug, according to a Tuesday disclosure on the Shenzhen bourse.The patent is for the medicinal use of a polypeptide as a treatment and prevention for diabetes, obesity and related diseases.This patent is a core patent covering the company's investigational innovative polypeptide drug RAY1225 Injection.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","002317","BK0239","BK0077","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652138022","title":"Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652138022","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652138022?lang=en_us&edition=fundamental","pubTime":"2026-07-20 19:55","pubTimestamp":1784548500,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, July  20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/20/3329651/0/en/Clearmind-Medicine-Expends-Global-IP-portfolio-with-Hong-Kong-Patent-Filing-for-Novel-Psychedelic-Compounds-Targets-Multi-Billion-Dollar-PTSD-Therapeutics-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WOOD","BK4136","IP","LENZ","LU1169589451.USD","USRD","LU2463526074.USD","LU1487256676.USD","BK4539","CUT","BK4588","LU1481599808.USD","BK4007","LU1169590202.USD","LU1481600234.SGD","IE00B3T34201.USD","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652298438","title":"Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2652298438","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652298438?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:02","pubTimestamp":1784530972,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Medivir AB ( ($SE:MVIR) ). Medivir AB has secured a Notice of Allowance from the United States Patent and Trade...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medivir-secures-long-term-u-s-patent-protection-for-fostrox-lenvatinib-liver-cancer-combination?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medivir-secures-long-term-u-s-patent-protection-for-fostrox-lenvatinib-liver-cancer-combination?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289960550.SGD","LU2543165471.USD","BK4535","LU0516423091.SGD","SG9999013478.USD","LU1839390173.USD","BK4585","LU0516422952.EUR","SG9999002406.SGD","LU0572940350.SGD","LU2177674079.SGD","SG9999002604.SGD","LU0441851309.USD","LU1048588211.SGD","LU2238330802.EUR","LU1242518931.SGD","LU0499858438.USD","LU0499858602.USD","SG9999014492.USD","LU1770036033.HKD","BK4548","LU0737861269.HKD","SG9999002414.USD","SE","LU2125910500.SGD","LU2125910849.SGD","LU0175139822.USD","SGXZ58947870.SGD","BK4566","BK4503","IE0001KFT4U8.USD","SG9999013460.SGD","SG9999004360.SGD","LU0261945553.USD","LU0823039010.USD","FDNI","IE00BD6J9T35.USD","LU0532188223.SGD","SG9999001135.SGD","SG9999002679.SGD","SG9999005177.SGD","BK4554","IE0031814969.USD","LU1861220207.SGD","LU2008162690.USD","LU0345775950.USD","LU0072462343.USD","BK4220","USRD","LU0348788117.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652265468","title":"Entropy Neurodynamics Granted South African Patent for Fibromyalgia Treatment Using Psilocybin","url":"https://stock-news.laohu8.com/highlight/detail?id=2652265468","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652265468?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:25","pubTimestamp":1784510734,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  said it was granted a patent in South Africa covering methods of treating fibromyalgia using psilocybin, with a term extended to September 2043, according to a Monday Australian bourse filing.The patent provides broad intellectual property protection covering the clinical use of psilocybin for the treatment of fibromyalgia, including therapeutic methods, dosing regimens, patient selection criteria, clinical assessment protocols, biomarkers, treatment outcome measures, integration therapy, and manufacture.The patent term is subject to the payment of annual renewal fees.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENP.AU","BK7096","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652288779","title":"VisionWave files provisional patent application for GhostSight","url":"https://stock-news.laohu8.com/highlight/detail?id=2652288779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652288779?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290525,"startTime":"0","endTime":"0","summary":"VisionWave (VWAV) announced the filing of a provisional patent application number 64/111,834 with the United States Patent and Trademark Office cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-for-ghostsight-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-for-ghostsight-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4187","USRD","VWAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652184401","title":"Arbutus Biopharma Reshapes Strategy After Moderna Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652184401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652184401?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:37","pubTimestamp":1784281058,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RND","BBP","MEDX","NXTI","BK4139","ABUS","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651444459","title":"Nuwellis awarded U.S. patent for Dual Lumen Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2651444459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651444459?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:35","pubTimestamp":1784205327,"startTime":"0","endTime":"0","summary":"Nuwellis (NUWE) announced that the U.S. Patent and Trademark Office , or USPTO, has issued U.S. Patent No. 12,678,592, covering the company’s Dual ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuwellis-awarded-u-s-patent-for-dual-lumen-catheter-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuwellis-awarded-u-s-patent-for-dual-lumen-catheter-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","USRD","NUWE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184549409","title":"Hainan Province Launches \"One-Stop\" Service Zone for Intellectual Property Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=1184549409","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184549409?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:00","pubTimestamp":1784188834,"startTime":"0","endTime":"0","summary":"Hainan Province has recently launched a dedicated \"One-Stop\" service zone for intellectual property protection, marking a significant step in streamlining related administrative services.This...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRND","LRND","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651499433","title":"UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651499433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651499433?lang=en_us&edition=fundamental","pubTime":"2026-07-16 05:10","pubTimestamp":1784149812,"startTime":"0","endTime":"0","summary":"Earlier this morning, the company stated: “UroGen Pharma (URGN) announced that it has received a Notice of Allowance from the U.S. Patent and Trade...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/urogen-pharma-gets-new-us-patent-allowance-into-july-2044-for-zusduri-ugn-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/urogen-pharma-gets-new-us-patent-allowance-into-july-2044-for-zusduri-ugn-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["URGN","USRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651665274","title":"NewcelX  announces Brazil patent for cell selection, enrichment technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2651665274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651665274?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:15","pubTimestamp":1784121348,"startTime":"0","endTime":"0","summary":"NewcelX (NCEL)announced that the Brazilian Patent and Trademark Office has issued a patent covering its cell selection and enrichment technology. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newcelx-announces-brazil-patent-for-cell-selection-enrichment-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newcelx-announces-brazil-patent-for-cell-selection-enrichment-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","EWZS","NCEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465112","title":"enVVeno Medical highlights newly issued U.S. patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651465112?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:55","pubTimestamp":1784120149,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor “What This Means...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-highlights-newly-issued-u-s-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-highlights-newly-issued-u-s-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVNO","BK4082","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651808463","title":"UroGen Pharma Receives US Patent Allowance for Zusduri, UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651808463","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651808463?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:30","pubTimestamp":1784118607,"startTime":"0","endTime":"0","summary":"UroGen Pharma  said Wednesday it has received a US patent allowance covering methods of treating patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer with Zusduri and investigational candidate UGN-103.The patent allowance is supported by data from two clinical trials and cover treatment without transurethral resection of a bladder tumor, the company said.The patent, once issued, is expected to expire in July 2044, UroGen said.Shares of the company were 1.1% higher in premarket activity Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["URGN","USRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463589","title":"UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463589","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., July  15, 2026  (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and spe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327670/0/en/UroGen-Receives-New-U-S-Patent-Allowance-Expected-to-Provide-Protection-into-July-2044-for-ZUSDURI-and-UGN-103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104592","title":"Seyond Holdings Reports Mixed Outcomes in LiDAR Patent Fight With Hesai","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651104592?lang=en_us&edition=fundamental","pubTime":"2026-07-14 22:08","pubTimestamp":1784038092,"startTime":"0","endTime":"0","summary":"TechStar Acquisition Corporation Class A ( ($HK:2665) ) has shared an announcement. Seyond Holdings has provided an update on four patent infringem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seyond-holdings-reports-mixed-outcomes-in-lidar-patent-fight-with-hesai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seyond-holdings-reports-mixed-outcomes-in-lidar-patent-fight-with-hesai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105400","title":"Immutep Granted New US Patent for Cancer Treatment Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105400","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105400?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:42","pubTimestamp":1784032963,"startTime":"0","endTime":"0","summary":"Immutep  said Tuesday it secured a new patent from the US Patent and Trademark Office covering methods for the treatment of cancer by administering eftilagimod alfa in combination with an antibody.The patent, entitled \"Combined Preparations for the Treatment of Cancer or Infection,\" expires Jan. 20, 2036, the company said.Immutep shares were 1.9% higher in premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","BK4139","IMMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651210540","title":"VisionWave Files Provisional Patent Application for SkyWeave Communication System","url":"https://stock-news.laohu8.com/highlight/detail?id=2651210540","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651210540?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:42","pubTimestamp":1784032921,"startTime":"0","endTime":"0","summary":"VisionWave (VWAV) said Tuesday it has filed a US provisional patent application for SkyWeave, an AI-driven high-frequency communication system designed to provide long-range connectivity without satel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4187","USRD","VWAV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":104,"code":"91000000","status":"200"}]}}